| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocardia, Inc. (BCDA) has 9 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. BCDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 293.3K | $283.5K | - | |
| CFO | 106.2K | $102.7K | - | |
| VP | 47.0K | $45.5K | - | |
| Dir | 15.7K | $15.2K | - | |
| Dir | 15.6K | $15.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2018 | Stertzer Simon H | Director | Buy | 5,000 | $1.50 | $7,500.00 | +0.2% | |
| Sep 18, 2018 | Altman Peter47 | President And CEO | Buy | 700 | $1.59 | $1,110.00 | - | |
| Sep 12, 2018 | Altman Peter47 | President And CEO | Buy | 1,600 | $1.37 | $2,184.00 | +0.1% | |
| Sep 5, 2018 | Altman Peter47 | President And CEO | Buy | 5,000 | $1.33 | $6,650.00 | +0.7% | |
| Aug 27, 2018 | Altman Peter47 | President And CEO | Buy | 1,500 | $1.46 | $2,190.00 | +0.2% | |
| Jun 11, 2018 | Altman Peter47 | President And CEO | Buy | 3,000 | $1.45 | $4,350.00 | +0.4% | |
| Apr 18, 2018 | Altman Peter47 | President And CEO | Buy | 1,000 | $1.45 | $1,450.00 | +0.1% | |
| Mar 26, 2018 | Stertzer Simon H | Director | Buy | 18,000 | $1.89 | $33,960.00 | +0.3% | |
| Mar 22, 2018 | McClung David | Chief Financial Officer | Buy | 500 | $1.90 | $950.00 | +66.7% | |
| Mar 22, 2018 | Stertzer Simon H | Director | Buy | 7,000 | $1.89 | $13,250.00 | +0.1% |